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Scabies outbreaks in ten care homes for elderly people: 
a prospective study of clinical features, epidemiology, 
and treatment outcomes
Jackie A Cassell, Jo Middleton, Ananth Nalabanda, Stefania Lanza, Michael G Head, Jennifer Bostock, Kirsty Hewitt, Christopher Iain Jones, 
Charles Darley, Simran Karir, Stephen L Walker
Summary
Background Scabies outbreaks in residential and nursing care homes for elderly people are common, subject to 
diagnostic delay, and hard to control. We studied clinical features, epidemiology, and outcomes of outbreaks in the 
UK between 2014 and 2015.
Methods We did a prospective observational study in residential care homes for elderly people in southeast England 
that reported scabies outbreaks to Public Health England health protection teams. An outbreak was defined as two or 
more cases of scabies (in either residents or staff) at a single care home. All patients who provided informed consent 
were included; patients with dementia were included if a personal or nominated consultee (ie, a family member or 
nominated staff member) endorsed participation. Dermatology-trained physicians examined residents at initial 
clinical visits, which were followed by two mass treatments with topical scabicide as per local health protection team 
guidance. Follow-up clinical visits were held 6 weeks after initial visits. Scabies was diagnosed through pre-defined 
case definitions as definite, probable, or possible with dermatoscopy and microscopy as appropriate.
Findings 230 residents were examined in ten outbreaks between Jan 23, 2014, and April 13, 2015. Median age was 
86·9 years (IQR 81·5–92·3), 174 (76%) were female, and 157 (68%) had dementia. 61 (27%) residents were diagnosed 
with definite, probable, or possible scabies, of whom three had crusted scabies. Physical signs differed substantially 
from classic presentations. 31 (51%) of the 61 people diagnosed with scabies were asymptomatic, and only 25 (41%) had 
burrows. Mites were visualised with dermatoscopy in seven (11%) patients, and further confirmed by microscopy in 
three (5%). 35 (57%) cases had signs of scabies only on areas of the body that would normally be covered. Dementia was 
the only risk factor for a scabies diagnosis that we identified (odds ratio 2·37 [95% CI 1·38–4·07]). At clinical follow-up, 
50 people who were initially diagnosed with scabies were examined. No new cases of scabies were detected, but 
infestation persisted in ten people.
Interpretation Clinical presentation of scabies in elderly residents of care homes differs from classic descriptions 
familiar to clinicians. This difference probably contributes to delayed recognition and suboptimal management in 
this vulnerable group. Dermatoscopy and microscopy were of little value. Health-care workers should be aware of the 
different presentation of scabies in elderly people, and should do thorough examinations, particularly in people with 
dementia.
Funding Public Health England and British Skin Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Scabies, a skin infestation with the mite Sarcoptes scabiei, 
is often intensely pruritic and distressing. Although 
clinicians frequently diagnose and treat scabies in children 
and young adults, very old people (ie, older than 85 years) 
can be highly affected, and outbreaks are common in 
residential and nursing care for elderly people.1–3 The 
mean diagnosed incidence in the UK between 1997 and 
2005 was 2·27 per 1000 men and 2·81 per 1000 women.1 
The 2015 global burden was 5 268 900 years lived with 
disability.4 Transmission is by direct close contact and, to a 
lesser extent, via fomites,5 with a 4–6 week incubation 
period in people never previously infested. Signs include 
papules, burrows, and nodules (figure 1).6 Excoriation due 
to scratching and parasite-induced inhibition of local 
immune response can lead to secondary bacterial 
infection,7 with resultant risks of impaired renal function 
and rheumatic heart disease.5,8 The normal parasitic 
burden is around 11 burrowing adult female mites per 
individual.9 However, some people develop crusted 
scabies, with hyperkeratotic skin lesions (figure 1) 
harbouring more than 4700 mites per g.10 Such patients 
have an increased mortality risk and are core transmitters 
during outbreaks.10,11
Scabies outbreaks in residential care homes for elderly 
people are challenging to diagnose, stigmatising, and 
costly to manage.11 The close proximity of individuals and 
lengthy asymptomatic incubation period enables many 
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residents and staff to become infested before detection, 
which is often delayed.3 Management of outbreaks 
comprises repeated simultaneous mass treatments with 
topical scabicide applied over the whole body and 
environmental decontamination.12 Mass treatments are 
logistically challenging, labour intensive, and can distress 
residents, many of whom have dementia and might not 
understand why they are receiving treatment.3 In a 
retrospective review11 of institutional scabies outbreaks 
(mainly in residential care homes for elderly people and 
hospitals), Mounsey and colleagues reported a median 
attack rate of 38% and that outbreaks usually persisted for 
many months, with cases of crusted scabies being the 
index in 83%.
Previous work has suggested that clinical presentation 
in elderly people might differ from that in younger age 
groups,13 and that diagnostic delay could contribute to 
outbreak size.3 However, no prospective studies so far 
have investigated clinical presentation in several out-
breaks with clear case definitions in the context of the 
host community. We hypothesised that differing clinical 
presentation in elderly people could contribute to delayed 
outbreak detection and suboptimal management. We 
aimed to establish the clinical characteristics of scabies 
in a population comprising elderly residents of UK care 
homes during an outbreak, resident characteristics 
predictive of scabies diagnosis, outbreak characteristics, 
and treatment effectiveness. In particular, we sought to 
characterise the distribution and duration of signs and 
symptoms and the course of outbreaks in this population.
Methods
Study design and participants
We did a prospective observational study between 
Jan 23, 2014, and April 13, 2015, in residential care homes 
for elderly people in southeast England that reported 
scabies outbreaks to Public Health England health 
protection teams. An outbreak was defined as two or more 
cases of scabies (in either residents or staff) at a single care 
home. All outbreaks were eligible for inclusion. Our study 
was approved by the Camberwell St Giles Research Ethics 
Committee. Informed consent was sought from all 
participants. Research staff did capacity assessments of 
residents with known cognitive impairment. If residents 
lacked capacity to consent, advice was sought from personal 
consultees (normally relatives) or nominated consultees 
(care home staff) as described elsewhere.14 The protocol is 
available online.
Procedures
Preliminary visits to each care home were done to 
gather data about outbreak characteristics, assess 
Research in context
Evidence before this study
This prospective study followed on from a needs assessment 
and a retrospective interview-based study of scabies outbreaks 
in residential care homes in southeast England done by some of 
the authors. For that needs assessment, PubMed was searched 
with the terms “scabies”, “care homes”, and “residential homes”, 
and Google Scholar was searched with the term “scabies care 
homes”, to identify articles in English published before 
Sept 11, 2010. The reference lists of articles identified by that 
search were also screened for inclusion. Eight case studies, 
six review articles, and five epidemiological studies were 
identified and included. The search showed that scabies 
outbreaks in residential and nursing care homes for elderly 
people are little studied, with no research on the topic in the UK 
before our work. However, the data and literature examined in 
the needs assessment, alongside the retrospective study, 
suggested that outbreaks are common in residential care 
homes, diagnosis is often delayed leading to avoidable 
transmission and distress, and clinical appearance of scabies in 
elderly populations was not what clinicians expected. We did a 
follow-up search of PubMed, Cinahl, Embase, and Web of 
Science for articles published in English up to July 19, 2017 
(the search string is in the appendix, p 7). We also used Google 
Scholar citation searching. Two relevant case reports were 
identified by this search, but neither included additional themes 
or clinical data to those shown by the needs assessment and 
retrospective study.
Added value of this study
In this study of ten scabies outbreaks in residential care homes for 
elderly people, we assessed risk factors, outbreak characteristics, 
and clinical presentation. To our knowledge, it is the largest 
prospective clinical study so far on this topic. We described how 
scabies presentation in this elderly population differed from 
classic descriptions, which are based on younger age groups. For 
example, the hands are a very common location for burrows in 
younger people, yet burrows were noted in only a minority of our 
elderly cohort. Furthermore, more than half of participants had 
physical signs only at sites normally covered by clothing, and 
more than half of those diagnosed were asymptomatic. We also 
showed that dementia is a risk factor for scabies in residential care 
homes, and described outbreak characteristics. The distinctive 
clinical characteristics in elderly populations, combined with the 
limited value of diagnostic tools, could contribute to delayed 
diagnosis.
Implications of all the available evidence
Scabies outbreaks are a common public health problem in 
residential care homes. To achieve timely outbreak detection 
and minimise transmission and distress in this vulnerable 
group, clinicians should be educated about the presentation of 
scabies in care homes, and novel diagnostics need to be 
developed. Topical mass treatments are distressing and labour 
intensive, so use of oral drugs should be considered in countries 
where they are not presently licensed for scabies.
For the trial protocol see http://
sro.sussex.ac.uk/66209/
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See Online for appendix residents’ mental capacity, and recruit participants. 
Residents were examined at initial clinical visits, which 
were followed by two mass treatments with topical 
scabicide according to local health protection team 
guidance. Follow-up clinical visits were arranged for 
approximately 6 weeks after initial visits, because 
symptoms can persist for up to 6 weeks after effective 
treatment,15 and experts suggest such symptoms should 
be investigated 4 weeks after treatment.16 Capacity was 
reassessed at both clinical visits before examination. 
We  used a prioritisation strategy for examinations 
(appendix p 1).
Data for age, mentia diagnosis (as recorded in care-
home records), continence, mobility, medical history, 
and medication use were collected at preliminary visits 
and initial clinical visits. Characteristics of 
homes and outbreaks that were recorded included 
demographics, number and proportion of residents 
affected, number and proportion treated, time to 
diagnosis, time to treatment, type of ownership, 
classification (with or without nursing), number of 
residents and maximum capacity, number of sections or 
floors, how the outbreak was detected, and number of 
staff affected. Scabies diagnostic criteria were developed 
(panel), and cases of crusted scabies were graded on the 
basis of the clinical scale devised by Davis and 
colleagues.17 Morphology and location of signs were 
recorded, with locations grouped into areas normally 
covered or uncovered (appendix p 2).
When possible, examinations were done by two clinicians 
working together (at 13 of 20 visits), who used 
dermatoscopes (Heine Delta 20 Plus; Heine Optotechnik, 
Figure 1: Scabies signs: papules (A), burrows (B), burrows under dermatoscopy (C), hyperkeratotic skin crusts (D), and Sarcoptes scabiei mites and eggs 
under × 10 microscopy (E)
A CB
ED
Panel: Scabies diagnostic criteria
Definite
Clinical features suggestive of scabies (ie, primary or secondary lesions*) plus a visible mite 
under dermatoscopy (positive delta wing sign) or a skin scraping or biopsy with identified 
mites, mite eggs, or faeces
Probable
Clinical features suggestive of scabies (ie, primary or secondary lesions*) at common sites 
of scabies infestation but no mite or mite products identified by dermatoscopy, 
skin scraping, or biopsy
Possible
Non-specific rash (which can include papules, vesicles, or pustules) at sites that are 
uncommon for scabies infestation; a positive family or social contact history with a 
definite case of scabies
Crusted
Clinical symptoms suggestive of scabies, hyperkeratotic skin crusts and skin fissuring 
as a result of hyperinfestation
*Primary lesions are burrows, papules, nodules, or vesicles; secondary lesions are excoriations due to scratching.
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Herrsching, Germany) and took clinical photographs as 
appropriate. The clinical team consisted of two 
consultant dermatologists and two primary care 
physicians with dermatology certification, and the same 
clinicians attended initial and follow-up visits 
(appendix p 3). Skin scrapes from participants with 
definite or probable scabies were examined under 
microscopy by senior specialist biomedical scientists the 
day after the sample was taken. Demographic and 
medical data were collected by consulting care-home 
staff and records (resident files, medication sheets, 
reports of clinician visits, hospital discharge letters, and 
ambulance-service assessments), usually at initial 
clinical visits. Time to diagnosis (in days) for individual 
residents with scabies was defined as the time between 
first awareness of signs or symptoms (earliest report by 
resident or staff, or earliest recording in care-home 
records) to date of diagnosis. We used a structured 
questionnaire to interview managers about home and 
outbreak characteristics. Death certificates were obtained 
from the UK General Register Office for all participants 
who died before follow-up. To reduce potential for bias at 
follow-up, study clinicians were not reminded of 
diagnoses made at initial visits.
Statistical analysis
Study size was based on the number of outbreaks 
reported to health protection teams that agreed to 
participate and could be visited before mass treatment 
within the funding period. A model was developed to 
predict diagnosis of scabies at initial clinical visit. 
Variables for the model were pre-specified to represent 
plausible causal pathways to an increased risk of scabies. 
We followed the rule of ten events per variable, because 
too many variables in the model would potentially result 
in overfitting. Data-reduction methods were used on the 
candidate list to reduce risk of multicollinearity, missing 
data, and sparsely populated categories (appendix p 2). 
We included a random effect to account for resident 
clustering within care homes. Because of the small 
number of clusters, normal distributions of test statistics 
would not have been a reasonable assumption, and so 
estimates were bootstrapped, and random samples were 
drawn with replacement. Adjusted odds ratios were 
calculated by fitting a logistic mixed-effects model for 
scabies diagnosis as a binary variable (no sign of scabies 
or diagnosis of scabies) with xtmelogit, with care home 
included as a random effect. Statistical analysis was done 
in Stata (version 14.1).
Role of the funding source
The study funders had no role in study design; data 
collection, analysis, or interpretation; or writing of the 
report. However, JAC and KH had honorary or 
substantive employment contracts with Public Health 
England (or its predecessor, the Health Protection 
Agency). The corresponding author had full access to all 
Figure 2: Participant profile
23 residents received only partial examinations at initial visits: 14 were distressed, two were in pain, one was sick, 
one refused examination, and five for other reasons. At follow-up, 16 received partial examinations: ten were 
distressed, two were in pain, one was sick, two had insufficient mobility, and one for another reason. 
*116 residents consented personally, whereas for 124 residents a personal consultee advised they would have 
wanted to participate had they had capacity; in a further 24 residents, a nominated consultee gave positive advice. 
†Includes two residents with crusted scabies, one of whom (with grade 2 crusted scabies) died 4 days after the 
initial visit. ‡Includes one resident with crusted scabies. Further data about clinical progression of examined 
residents at follow-up is included in the appendix (p8).
10 had signs of scabies 
 (8 probable, 2 possible) 
40 had no signs of scabies136 had no signs of scabies
50 re-examined at follow-up136 re-examined at follow-up
169 had no signs of scabies 61 diagnosed with scabies 
 (7 definite†, 28 probable‡, 
 and 26 possible cases)
33 not examined
       8 in home to undergo
           reablement or 
  rehabilitation at first 
           visit only
 7 died
 7  too ill or distressed
 5 in hospital
 3 missing
 2 refused examination
 1 unable to schedule 
  appointment
 
11 not examined
 6 died
 2 unable to schedule 
  appointment
 2 in home to undergo
           reablement or 
  rehabilitation at first 
           visit only
 1  too ill or distressed
230 examined by study team 
264 eligible for inclusion in study*
34 not examined
 23 because of time constraints
 5 refused examination
 3 too ill or distressed
 2 in hospital
 1 unable to schedule appointment
295 approached to give consent for study inclusion
31 did not consent
 21 refused to provide consent
 10 personal consultee advised residents would not
             have consented
430 residents at ten care homes with scabies outbreaks
135 not approached for inclusion
 63 care-home restrictions   
 60 because of time constraints
 7 too ill or distressed
 3 in hospital
 2 unable to schedule appointment
Articles
898 www.thelancet.com/infection   Vol 18   August 2018 
the data in the study and had final responsibility for the 
decision to submit for publication.
Results
33 scabies outbreaks were reported to the study. Seven care 
homes did not wish to take part, and we could not schedule 
visits without delaying mass treatment at a further 16. 
Thus, ten homes with 430 residents were visited. 
Preliminary visits to homes took place a median of 2 days 
(IQR 1–7) after health protection teams reported outbreaks 
to us. Initial clinic visits were done a median of 5 days 
(IQR 3–8, not including one pilot visit done 5 days after 
initial treatment) after notification of outbreak.
 135 of these residents were not approached for inclusion 
(figure 2). The mental capacity of the remaining 
295 residents was assessed. 144 (49%) had capacity to 
consent, 151 (51%) did not). 230—who either consented 
or, if they were unable to do so, had a designated consultee 
endorse participation on their behalf—were examined at 
initial clinical visits (figure 2). 186 (81%) patients were 
examined at follow up (figure 2). Median age was 
86·9 years (IQR 81·5–92·3), and the age distribution of 
participants was similar to national estimates of age 
at admission to residential and nursing care homes 
(appendix p 7).18 174 residents (76%) were female, and 
157 (68%) had dementia (table 1). The extent of 
polypharmacy and comorbidity did not differ noticeably 
between patients with scabies and those without scabies 
(data not shown).
Seven of the homes were owned privately, and 
three were owned by local authorities. Four homes 
provided nursing care. At two homes, all residents were 
registered with one primary care practice, whereas at all 
the others residents had primary care physicians from 
several practices. Two homes had had earlier scabies 
outbreaks in the previous 5 years. Six were smaller than 
the UK mean of 40 beds, and all were located in a region 
in which the proportion of self-funded residents is 
relatively high.19
A median of seven (IQR 3–10; range 2–11) residents per 
home were diagnosed with scabies at initial clinical 
visits, or previously by other clinicians (appendix p 6). 
Four homes had at least one case of crusted scabies. At 
two homes, these cases were diagnosed by the study 
team, whereas at the other two they had already been 
diagnosed by other clinicians (appendix p 6). Overall, 
median time to diagnosis was 22 days (IQR 7·5–186; 
n=48; appendix p 6). In eight homes, at least one staff 
member was diagnosed with scabies (either by study 
clinicians or others). Although offered, staff were not 
examined at the other two homes. Scabies outbreaks 
reported to health protection teams were overwhelmingly 
located in residential and nursing care homes and 
attributed to transmission within that setting. The 
outbreaks we attended had no unusual features and were 
similar to those described in our previous non-clinical 
studies in the same region (appendix p 6).3
At initial clinical visits, 61 (27%) residents were 
diagnosed with scabies: seven definite (including 
two crusted), 28 probable (including one crusted), and 
26 possible (figure 2). Burrows were detected in 
25 (41%) cases, papules in 52 (85%), hyperkeratosis in 
eight (13·1%), and nodules in four (7%). Figure 3 shows 
the distribution of signs, and resident profiles are in the 
appendix (pp 3–4). The torso was the most common 
location for burrows, hyperkeratosis, and papules 
(figure 3). 35 (57%) cases only had signs on normally 
Overall (n=230) Initial scabies diagnosis
No sign of scabies 
(n=169)
Possible, probable, or 
definite scabies (n=61)
Sex
Female 174 (76%) 130 (77%) 44 (72%)
Male 56 (24%) 39 (23%) 17 (28%)
Age group, years
<70 14 (6%) 9 (5%) 5 (8%)
70–74 8 (3%) 6 (4%) 2 (3%)
75–79 29 (13%) 20 (12%) 9 (15%)
80–84 35 (15%) 28 (17%) 7 (11%)
85–89 62 (27%) 46 (27%) 16 (26%)
90–94 55 (24%) 37 (22%) 18 (30%)
95–99 23 (10%) 19 (11%) 4 (7%)
>100 4 (2%) 4 (2%) 0
Median (IQR) 86·9 (81·5–92·3) 87·0 (81·7–92·5) 86·4 (79·8–91·9)
Dementia
No 73 (32%) 58 (34%) 15 (25%)
Yes 157 (68%) 111 (66%) 46 (75%)
Continence
Continent 80 (35%) 59 (35%) 21 (34%)
Urinary incontinence 44 (19%) 33 (20%) 11 (18%)
Faecal incontinence 5 (2%) 4 (2%) 1 (2%)
Urinary and faecal incontinence 101 (44%) 73 (43%) 28 (46%)
Mobility
Mobile 151 (66%) 108 (64%) 43 (70%)
Transfer with help 50 (22%) 35 (21%) 15 (25%)
Bedbound 22 (10%) 19 (11%) 3 (5%)
Other 7 (3%) 7 (4%) 0
Resident type
Not collected 27 (12%) 18 (11%) 9 (15%)
Permanent 176 (77%) 131 (78%) 45 (74%)
Respite 16 (7%) 13 (8%) 3 (5%)
Other 11 (5%) 7 (4%) 4 (7%)
Conditions or therapies affecting immunity
Cancer 31 (13%) 24 (14%) 7 (11%)
Diabetes 35 (15%) 26 (15%) 9 (15%)
Topical corticosteroids 41 (18%) 27 (16%) 14 (23%)
Systemic corticosteroids 10 (4%) 9 (5%) 1 (2%)
Nutritional problems 30 (13%) 20 (12%) 10 (16%)
Other 14 (6%) 9 (5%) 5 (8%)
Data are n (%), unless otherwise specified.
Table 1: Resident demographics and scabies diagnoses
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covered areas of the body, including 18 (72%) of the 
25 residents with burrows (figure 3). A scabies mite was 
visualised via dermatoscopy in seven infested 
residents (11%). Three of these residents also had positive 
microscopy results. Among residents not diagnosed with 
scabies, none had burrows, nodules, or hyperkeratosis, 
but five had papules (located on the torso of three 
residents, the hands of one, and the legs of one). Of 
residents with scabies diagnoses, staff reported that 
31 (51%) had not complained of itch, rash, or scratching 
(table 2). 24 of these asymptomatic residents had 
dementia. Of the 16 diagnosed residents who had 
complained about these symptoms, only nine had 
complained of itch (table 2). Staff did not notice skin 
signs in 12 (20%) subsequently diagnosed residents. In 
13 of the asymptomatic residents with scabies, signs 
were present only in areas normally covered by clothing.
Among residents who underwent examination, 
dementia was significantly associated with a scabies 
diagnosis at the initial clinical visit (odds ratio [OR] 2·37 
[95% CI 1·38–4·07]). Age (OR 0·99 [95% CI 0·93–1·04]), 
mobility (0·53 [0·22–1·25]), sex (1·61 [0·84–3·07]), 
continence (1·28 [0·53–3·11]), or conditions suppressing 
immunity (ie, known cancer patient, diabetes mellitus, 
topical steroids, on systemic steroids; 0·95 [0·51–1·76]) 
were not significantly associated with scabies diagnosis 
(appendix p 2). The intracluster correlation coefficient for 
residents within homes was 0·214, suggesting that 
clustering of data had a large effect.
In all homes, two mass treatments with topical 
scabicide were administered a median of 7 days apart 
(IQR 7–7; appendix p 5). Seven (3%) residents were not 
included in the first treatment, and seven (3%) were not 
included in the second. Because most homes obtained 
prescriptions from primary care physicians at more than 
one practice, arrangement of prescriptions and sufficient 
scabicide delayed treatment. Two participants living in 
separate homes were given oral ivermectin (appendix p 6). 
Staff reported that mass treatments were labour 
intensive, and many residents found the process 
distressing (data not shown). Some staff suggested oral 
treatment would be preferable (data not shown). In 
two of the four homes with cases of crusted scabies, 
residents with crusted scabies died before treatment 
completion (figure 2; appendix p 6). 
No new cases of scabies were detected at follow-up 
visits, which were a median of 44 days (IQR 41–48) after 
initial clinical visits and 35 days (31–39) after second 
mass treatments. 50 of the 61 previously diagnosed 
residents were examined. 40 had no signs, and ten had 
either probable or possible scabies (appendix p 8). Nine 
of these residents had been included in the first mass 
treatment, and all had been included in the second. None 
had deteriorated, and seven had improved clinical 
classification (figure 2). Six (10%) of the 61 residents 
diagnosed with scabies died before follow-up, compared 
with seven (4%) of 169 of those with no signs of scabies 
Figure 3: Clinical presentation of scabies in elderly care-home residents
Percentages in the figure are the proportion of residents with scabies who had that sign at that location. 
Percentages below the figures are the number of residents with the sign only in covered locations, out of all the 
people with that sign. Locations that would normally be covered by clothing are the upper limbs, torso (including 
back), lower limbs, and genitalia. The wrist was considered to be part of the upper limb, separate from the hands. 
This heatmap was generated from individual patient descriptions, which provide more detail on the locations of 
signs (appendix pp 3–4).
15 (25%) 44 (72%) 2 (3%) 4 (7%)
2 (3%)
2 (3%)
2 (3%)
2 (3%)
2 (3%)1 (2%)31 (51%)6 (10%)
5 (8%)17 (28%)7 (11%)
1 (2%)1 (2%)17 (28%)2 (3%)
*3 (5%) *1 (2%)
**
Burrows Papules Nodules HyperkeratosisSign
18 (72%) of 25 34 (65%) of 52 4 (100%) of 4 3 (38%) of 8Sign present
at covered
areas only
Not seen Seen in one resident log2(1) Seen in all residents log2(61)
Overall 
(n=230)
Scabies diagnosis at initial visit
No sign of 
scabies 
(n=169)
Possible, probable, 
or definite scabies 
(n=61)
Skin symptoms
Resident complained about skin-related symptoms
No 137 (60%) 106 (63%) 31 (51%)
Yes 38 (17%) 22 (13%) 16 (26%)
Unknown* 55 (24%) 41 (24%) 14 (23%)
Type (if present)
Itch 29 (76%) 20 (91%) 9 (56%)
Scratching 10 (26%) 4 (18%) 6 (38%)
Rash 13 (34%) 5 (23%) 8 (50%)
Skin signs
Staff noticed skin-related signs
No 128 (56%) 116 (69%) 12 (20%)
Yes 82 (36%) 35 (21%) 47 (77%)
Unknown 20 (9%) 18 (11%) 2 (3%)
Type (if present)
Itch† 41 (50%) 17 (49%) 24 (51%)
Scratching 26 (32%) 9 (26%) 17 (36%)
Rash 46 (56%) 15 (43%) 31 (66%)
*Includes 23 residents (eight with scabies) from a pilot outbreak visit at which 
information about skin-related symptoms was not recorded. †Although itch 
is not a sign, staff were asked whether they noticed residents who seemed 
itchy.
Table 2: Description of skin signs and symptoms in residents before 
initial clinical visits as reported by care-home staff
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(appendix p 5). One resident with crusted scabies 
(confirmed by microscopy) died in hospital 4 days after 
the initial clinical visit, with scabies recorded on their 
death certificate as a significant contributing condition 
(appendix p 7).
Discussion
In our investigation of the characteristics of scabies in 
residential and nursing care homes, signs and symptoms 
of scabies differed from classic presentation. 51% of 
diagnosed residents were asymptomatic. By contrast 
with classic scabies presentation, signs were distributed 
largely in areas normally covered by clothing, including 
in participants in whom burrows were detected. A 
dementia diagnosis was predictive of scabies. Outbreaks 
were often characterised by substantial diagnostic delay, 
and a case of crusted scabies was detected at four care 
homes. Topical mass treatment was effective but 
distressing for residents, labour intensive, and did not 
result in complete resolution of signs of scabies in 20% of 
residents who were re-examined at follow-up.
Our study had several limitations. Scabies outbreaks 
attract stigma.11 Selection bias could thus have been 
introduced at recruitment, which was dependent upon 
care homes informing health protection teams and 
agreeing to participate. Most diagnoses were based on 
clinical signs rather than visual confirmation of mite 
presence. We were unable to examine all residents 
(figure 2; appendix p 6), and thus we cannot report attack 
rates. We did not access primary care or hospital records, 
and the accuracy of care-home records is difficult to 
establish. Our presence could have encouraged more 
thorough treatments, biasing measurement of their 
success.
The most common sign or symptom of scabies is 
itching, and the interdigital web spaces of the hands are 
the classic locations for signs.15,20 However, non-classic 
presentation has been reported in elderly people in case 
reports and small studies.13,16,21 Our study also shows that 
presentation in elderly people in similar age ranges can 
differ substantially from the standard description of 
scabies15 and from clinical phenotypes, which are based 
primarily on paediatric populations and do not 
differentiate elderly populations as a distinct group.22 In 
our study, more than half of residents with scabies were 
asymptomatic, and many had subtle clinical signs at 
locations that were usually covered, which could have 
been missed by clinicians focusing on the sites 
commonly affected in younger age groups. Skin signs 
had gone unnoticed by staff in many cases. Burrows are 
pathognomonic of scabies, and hands are a typical site. 
In one study23 of male soldiers, occupied burrows were 
detected on the hands or wrists in 85% of 886 infested 
participants. By contrast, in our study, burrows were 
identified in only 25 (41%) patients, and were detected on 
the hands of only seven (12%). The extent of unexpected 
and hidden signs and symptoms in this population could 
partly explain reported delayed diagnosis. Educational 
materials are needed to support diagnosis of scabies in 
residential care homes by primary care physicians and 
others.
Dermatoscopy was of limited value in our study, with a 
mite visualised in only seven (11%) participants. In a 
French hospital-based study24 (mean participant age 
33 years), dermatoscopy had 91% sensitivity, whereas in a 
Brazilian community-based study25 (median participant 
age 14 years), it had 83% sensitivity (appendix p 7). In the 
French study, 75% of cases had “involvement of typical 
body areas”. Our dermatoscopy findings might differ from 
those in previous studies because our cohort was 
substantially older and had different clinical features. A 
review11 by Mounsey and colleagues included 40 outbreaks 
in “aged care” facilities, but dermatoscopy was used in 
only one study (appendix p 7), and the proportion of 
affected individuals in whom a mite was visualised was 
not reported. The role of dermatoscopy in elderly people 
with suspected scabies warrants further study. In line with 
previous reports,26,27 inspection of skin scrapings under 
microscopy, although useful for confirmation of positive 
diagnoses, was not highly sensitive. Alternative diagnostics 
need to be developed. In their absence, diagnosis will 
remain clinical. Primary care physicians might be 
reluctant to diagnose scabies in the absence of classic 
signs, especially if patients are asymptomatic, because of 
the implications for homes and residents.3 Our case 
definitions (panel) could be helpful, and that all but three 
of those examined at post-treatment follow-up had 
improved clinical classification lends weight to them. 19 of 
the 21 cases previously classified as possible were classified 
as no signs at post-treatment follow-up (appendix p 9). We 
suspect that the other two possible cases, which had not 
improved at follow-up, were not scabies.
To our knowledge, our study is the first to show that 
dementia is a risk factor for scabies in residential and 
nursing care homes. The explanation for this association 
remains unclear, but wandering behaviours and 
increased number of physical contacts could heighten 
transmission hazard.28 Cognitive impairment could also 
support infestation by reducing removal of mites through 
scratching.13 This increased risk should be considered 
when deciding whether to examine residents with 
dementia, who can have difficulty understanding and 
communicating symptoms. Distress caused by scabies 
could lead to changes in behaviour, which might 
mistakenly be attributed to the underlying cognitive 
condition rather than to the effect of scabies.
Mounsey and colleagues11 outlined common characte- 
ristics of institutional scabies outbreaks, many of which 
were evident in our study. These characteristics included 
protracted, delayed diagnoses (months to years in some 
homes in our study), residents with crusted scabies 
(four of the ten outbreaks in our study included at least 
one case), and infestation of staff (present in all homes 
in our study in which staff examinations took place). In 
Articles
www.thelancet.com/infection   Vol 18   August 2018  901
agreement with some studies in that review, staff in our 
study reported considerable anxiety and frustration 
among patients and personally. Eight of the ten care 
homes in our study did not have a sole primary care 
practice responsible for all residents. Other care homes 
with similar arrangements could also experience 
impaired communication and delayed case diagnosis and 
outbreak detection as a result of this set-up.
Although topical scabicide treatments seemed 
successful, their efficacy could have been exaggerated by 
early exit of some participants with scabies—and 
particularly by the high number of deaths in the study. In 
half the homes with cases of crusted scabies, residents 
with crusted scabies died before mass treatment was 
finished. These patients could have been core 
transmitters, and, in view of the difficulty treating crusted 
scabies topically, their exit from the cohort could have 
contributed to absence of a recurrent outbreak. The 
distress and logistic challenges of topical mass treatments 
reported in this study and in previous work3 suggest that 
use of oral drugs should be considered. A suggested link 
between oral ivermectin treatment for scabies and excess 
deaths in elderly people in a much criticised 1997 study29 
has not been reproduced.12 Ivermectin has an extremely 
good safety profile in mass drug administration 
programmes for filariasis and onchocerciasis.30 In settings 
where scabies prevalence is of epidemic proportions, oral 
ivermectin seems more effective than topical therapy.30 
France has licensed oral ivermectin for scabies outbreaks 
in residential care homes, but in the UK the drug remains 
available only on a named patient basis and is 
recommended for treatment-resistant crusted scabies 
only.12 We recommend research in residential care homes 
comparing oral ivermectin—or novel oral treatments 
such as moxidectin31—with topical scabicides.
Care-home residents are a vulnerable population 
requiring advocacy. In 2011, 291 000 people aged 65 years 
or older lived in care homes in England and Wales,32 
many of whom have complex health-care needs, yet the 
sector is arguably under-researched. Our study enabled 
participation in research by people with dementia. Key 
findings would not have been discovered had we not 
included such people, whose inclusion was made possible 
by advice on innovative methods from patient re- 
presentatives. We recommend researchers consider our 
methods14 in outbreak and other time-critical studies in 
care homes. Ours was the first funded UK research on 
scabies outbreaks in care homes. The burden, effect, and 
management of scabies in care homes warrants further 
study, not least because, as the global population ages, the 
burden of skin disease in elderly people is expected to 
become a substantial challenge,33 and institutional disease 
outbreaks place substantial demands on scarce resources.
Care-home residents with scabies might be asymp-
tomatic, and can have subtle signs at covered sites not 
typically affected in young people. We recommend 
thorough, careful examination, particularly of individuals 
with dementia, who are at increased risk of scabies. The 
need for thorough clinical examination is shown by the 
limited value of diagnostic tools. Scabies outbreaks are 
difficult to manage, distressing, and highly stigmatising. 
Increased awareness of how scabies presents in elderly 
people, alongside development of diagnostics and 
evidence-based treatment regimens, would help with 
detection and control of scabies outbreaks.
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